Common side effects include nausea, vomiting, diarrhea, constipation, decreased appetite, indigestion, and stomach pain
Metabolic Flexibility and Substrate Utilization Dual agonism may promote greater metabolic flexibility by influencing both glucose and lipid metabolism through complementary mechanisms
Tirzepatide (Mounjaro), a dual GIP/GLP-1 receptor agonist, shows dose-dependent nausea rates, ranging from approximately 12-18% at lower doses to higher rates at doses used for weight management, as demonstrated in the SURPASS-2 trial comparing it with semaglutide
They can be caused by slow digestion, eating foods high in sulfur (eggs, broccoli, or garlic), or changes in gut bacteria
30min przed posikiem , aby utrzyma jej stay poziom we krwi
But if you have diabetes, you might be confused and maybe concerned when it comes to fruit